世界のソマトスタチン市場レポート2020年

【英語タイトル】Global Somatostatin Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB13828)・商品コード:QYR21FB13828
・発行会社(調査会社):QYResearch
・発行日:2021年1月(※2024年版があります。お問い合わせください)
・ページ数:140
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のソマトスタチン市場について種類別(0.25、0.75、3)、用途別(ホルモン障害、腫瘍、代謝障害、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ソマトスタチン市場の概要
・世界の主要地域別ソマトスタチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のソマトスタチン市場規模2015-2026:種類別(0.25、0.75、3)
・世界のソマトスタチン市場規模2015-2026:用途別(ホルモン障害、腫瘍、代謝障害、その他)
・ソマトスタチンのアメリカ市場規模2015-2020
・ソマトスタチンのヨーロッパ市場規模2015-2020
・ソマトスタチンの中国市場規模2015-2020
・ソマトスタチンの日本市場規模2015-2020
・ソマトスタチンの東南アジア市場規模2015-2020
・ソマトスタチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ソマトスタチンの製造コスト分析
・販売チャネル、流通業者、顧客
・ソマトスタチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world’s most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital.

Market Analysis and Insights: Global Somatostatin Market
The global Somatostatin market size is projected to reach US$ 577.4 million by 2026, from US$ 302.1 million in 2020, at a CAGR of 11.4% during 2021-2026.

Global Somatostatin Scope and Market Size
The global Somatostatin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Somatostatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Somatostatin market is segmented into
0.25
0.75
3

Segment by Application, the Somatostatin market is segmented into
Hormonal Disorder
Oncology
Metabolic Disorder
Others

The Somatostatin market is analysed and market size information is provided by regions (countries). Segment by Application, the Somatostatin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Somatostatin Market Share Analysis
Somatostatin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Somatostatin business, the date to enter into the Somatostatin market, Somatostatin product introduction, recent developments, etc.

The major vendors covered:
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin

【レポートの目次】

1 Somatostatin Market Overview
1.1 Somatostatin Product Scope
1.2 Somatostatin Segment by Type
1.2.1 Global Somatostatin Sales by Type (2020-2026)
1.2.2 0.25
1.2.3 0.75
1.2.4 3
1.3 Somatostatin Segment by Application
1.3.1 Global Somatostatin Sales Comparison by Application (2020-2026)
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Somatostatin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Somatostatin Sales Growth Rate (2015-2026)
1.4.2 Global Somatostatin Revenue and Growth Rate (2015-2026)
1.4.3 Global Somatostatin Price Trends (2015-2026)

2 Somatostatin Estimate and Forecast by Region
2.1 Global Somatostatin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Somatostatin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Somatostatin Sales Market Share by Region (2015-2020)
2.2.2 Global Somatostatin Revenue Market Share by Region (2015-2020)
2.3 Global Somatostatin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Somatostatin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Somatostatin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Somatostatin Estimates and Projections (2015-2026)
2.4.2 Europe Somatostatin Estimates and Projections (2015-2026)
2.4.3 China Somatostatin Estimates and Projections (2015-2026)
2.4.4 Japan Somatostatin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Somatostatin Estimates and Projections (2015-2026)
2.4.6 India Somatostatin Estimates and Projections (2015-2026)
3 Global Somatostatin Competition Landscape by Players
3.1 Global Top Somatostatin Players by Sales (2015-2020)
3.2 Global Top Somatostatin Players by Revenue (2015-2020)
3.3 Global Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin as of 2019)
3.4 Global Somatostatin Average Price by Company (2015-2020)
3.5 Manufacturers Somatostatin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Somatostatin Players (Opinion Leaders)
4 Global Somatostatin Market Size by Type
4.1 Global Somatostatin Historic Market Review by Type (2015-2020)
4.1.1 Global Somatostatin Sales Market Share by Type (2015-2020)
4.1.2 Global Somatostatin Revenue Market Share by Type (2015-2020)
4.1.3 Global Somatostatin Price by Type (2015-2020)
4.2 Global Somatostatin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Somatostatin Sales Forecast by Type (2021-2026)
4.2.2 Global Somatostatin Revenue Forecast by Type (2021-2026)
4.2.3 Global Somatostatin Price Forecast by Type (2021-2026)
5 Global Somatostatin Market Size by Application
5.1 Global Somatostatin Historic Market Review by Application (2015-2020)
5.1.1 Global Somatostatin Sales Market Share by Application (2015-2020)
5.1.2 Global Somatostatin Revenue Market Share by Application (2015-2020)
5.1.3 Global Somatostatin Price by Application (2015-2020)
5.2 Global Somatostatin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Somatostatin Sales Forecast by Application (2021-2026)
5.2.2 Global Somatostatin Revenue Forecast by Application (2021-2026)
5.2.3 Global Somatostatin Price Forecast by Application (2021-2026)

6 United States Somatostatin Market Facts & Figures
6.1 United States Somatostatin Sales Market Share by Company (2015-2020)
6.2 United States Somatostatin Sales Market Share by Type (2015-2020)
6.3 United States Somatostatin Sales Market Share by Application (2015-2020)

7 Europe Somatostatin Market Facts & Figures
7.1 Europe Somatostatin Sales Market Share by Company (2015-2020)
7.2 Europe Somatostatin Sales Market Share by Type (2015-2020)
7.3 Europe Somatostatin Sales Market Share by Application (2015-2020)

8 China Somatostatin Market Facts & Figures
8.1 China Somatostatin Sales Market Share by Company (2015-2020)
8.2 China Somatostatin Sales Market Share by Type (2015-2020)
8.3 China Somatostatin Sales Market Share by Application (2015-2020)

9 Japan Somatostatin Market Facts & Figures
9.1 Japan Somatostatin Sales Market Share by Company (3015-3030)
9.2 Japan Somatostatin Sales Market Share by Type (2015-2020)
9.3 Japan Somatostatin Sales Market Share by Application (2015-2020)

10 Southeast Asia Somatostatin Market Facts & Figures
10.1 Southeast Asia Somatostatin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Somatostatin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Somatostatin Sales Market Share by Application (2015-2020)

11 India Somatostatin Market Facts & Figures
11.1 India Somatostatin Sales Market Share by Company (2015-2020)
11.2 India Somatostatin Sales Market Share by Type (2015-2020)
11.3 India Somatostatin Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Somatostatin Business
12.1 Merck (Schweiz) AG
12.1.1 Merck (Schweiz) AG Corporation Information
12.1.2 Merck (Schweiz) AG Business Overview
12.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck (Schweiz) AG Somatostatin Products Offered
12.1.5 Merck (Schweiz) AG Recent Development
12.2 SANOFI-AVENTIS FRANCE
12.2.1 SANOFI-AVENTIS FRANCE Corporation Information
12.2.2 SANOFI-AVENTIS FRANCE Business Overview
12.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 SANOFI-AVENTIS FRANCE Somatostatin Products Offered
12.2.5 SANOFI-AVENTIS FRANCE Recent Development
12.3 Lyomark Pharma GmbH
12.3.1 Lyomark Pharma GmbH Corporation Information
12.3.2 Lyomark Pharma GmbH Business Overview
12.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Lyomark Pharma GmbH Somatostatin Products Offered
12.3.5 Lyomark Pharma GmbH Recent Development
12.4 ALFA WASSERMANN S.p.A.
12.4.1 ALFA WASSERMANN S.p.A. Corporation Information
12.4.2 ALFA WASSERMANN S.p.A. Business Overview
12.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 ALFA WASSERMANN S.p.A. Somatostatin Products Offered
12.4.5 ALFA WASSERMANN S.p.A. Recent Development
12.5 Polypeptide Laboratories, Inc
12.5.1 Polypeptide Laboratories, Inc Corporation Information
12.5.2 Polypeptide Laboratories, Inc Business Overview
12.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Polypeptide Laboratories, Inc Somatostatin Products Offered
12.5.5 Polypeptide Laboratories, Inc Recent Development
12.6 SAMARTH
12.6.1 SAMARTH Corporation Information
12.6.2 SAMARTH Business Overview
12.6.3 SAMARTH Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 SAMARTH Somatostatin Products Offered
12.6.5 SAMARTH Recent Development
12.7 UBPL
12.7.1 UBPL Corporation Information
12.7.2 UBPL Business Overview
12.7.3 UBPL Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 UBPL Somatostatin Products Offered
12.7.5 UBPL Recent Development
12.8 HYBIO
12.8.1 HYBIO Corporation Information
12.8.2 HYBIO Business Overview
12.8.3 HYBIO Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 HYBIO Somatostatin Products Offered
12.8.5 HYBIO Recent Development
12.9 TianTaiShan
12.9.1 TianTaiShan Corporation Information
12.9.2 TianTaiShan Business Overview
12.9.3 TianTaiShan Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 TianTaiShan Somatostatin Products Offered
12.9.5 TianTaiShan Recent Development
12.10 Yangtze River
12.10.1 Yangtze River Corporation Information
12.10.2 Yangtze River Business Overview
12.10.3 Yangtze River Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Yangtze River Somatostatin Products Offered
12.10.5 Yangtze River Recent Development
12.11 Siyao
12.11.1 Siyao Corporation Information
12.11.2 Siyao Business Overview
12.11.3 Siyao Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Siyao Somatostatin Products Offered
12.11.5 Siyao Recent Development
12.12 Shuangcheng
12.12.1 Shuangcheng Corporation Information
12.12.2 Shuangcheng Business Overview
12.12.3 Shuangcheng Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Shuangcheng Somatostatin Products Offered
12.12.5 Shuangcheng Recent Development
12.13 Hainan Zhonghe
12.13.1 Hainan Zhonghe Corporation Information
12.13.2 Hainan Zhonghe Business Overview
12.13.3 Hainan Zhonghe Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hainan Zhonghe Somatostatin Products Offered
12.13.5 Hainan Zhonghe Recent Development
12.14 SL PHARM
12.14.1 SL PHARM Corporation Information
12.14.2 SL PHARM Business Overview
12.14.3 SL PHARM Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.14.4 SL PHARM Somatostatin Products Offered
12.14.5 SL PHARM Recent Development
12.15 Wuhan Hualong
12.15.1 Wuhan Hualong Corporation Information
12.15.2 Wuhan Hualong Business Overview
12.15.3 Wuhan Hualong Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Wuhan Hualong Somatostatin Products Offered
12.15.5 Wuhan Hualong Recent Development
12.16 Qingdao Guoda
12.16.1 Qingdao Guoda Corporation Information
12.16.2 Qingdao Guoda Business Overview
12.16.3 Qingdao Guoda Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Qingdao Guoda Somatostatin Products Offered
12.16.5 Qingdao Guoda Recent Development
12.17 Chengdu Shengnuo
12.17.1 Chengdu Shengnuo Corporation Information
12.17.2 Chengdu Shengnuo Business Overview
12.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Chengdu Shengnuo Somatostatin Products Offered
12.17.5 Chengdu Shengnuo Recent Development
12.18 Longjin
12.18.1 Longjin Corporation Information
12.18.2 Longjin Business Overview
12.18.3 Longjin Somatostatin Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Longjin Somatostatin Products Offered
12.18.5 Longjin Recent Development

13 Somatostatin Manufacturing Cost Analysis
13.1 Somatostatin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Somatostatin
13.4 Somatostatin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Somatostatin Distributors List
14.3 Somatostatin Customers

15 Market Dynamics
15.1 Somatostatin Market Trends
15.2 Somatostatin Opportunities and Drivers
15.3 Somatostatin Market Challenges
15.4 Somatostatin Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Somatostatin Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Somatostatin Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Somatostatin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Somatostatin Sales (K Pcs) by Region (2015-2020)
Table 5. Global Somatostatin Sales Market Share by Region (2015-2020)
Table 6. Global Somatostatin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Somatostatin Revenue Share by Region (2015-2020)
Table 8. Global Somatostatin Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Somatostatin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Somatostatin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Somatostatin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Somatostatin (K Pcs) of Key Companies (2015-2020)
Table 13. Global Somatostatin Sales Share by Company (2015-2020)
Table 14. Global Somatostatin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Somatostatin Revenue Share by Company (2015-2020)
Table 16. Global Somatostatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin as of 2019)
Table 17. Global Somatostatin Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Somatostatin Manufacturing Sites and Area Served
Table 19. Manufacturers Somatostatin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Somatostatin Players
Table 22. Global Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 23. Global Somatostatin Sales Share by Type (2015-2020)
Table 24. Global Somatostatin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Somatostatin Price (K Pcs) by Type (2015-2020)
Table 26. Global Somatostatin Sales Share by Type (2021-2026)
Table 27. Global Somatostatin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Somatostatin Revenue Share by Type (2021-2026)
Table 29. Global Somatostatin Price (K Pcs) by Type (2021-2026)
Table 30. Global Somatostatin Sales (K Pcs) by Application (2015-2020)
Table 31. Global Somatostatin Sales Share by Application (2015-2020)
Table 32. Global Somatostatin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Somatostatin Price (K Pcs) by Application (2015-2020)
Table 34. Global Somatostatin Sales (K Pcs) by Application (2021-2026)
Table 35. Global Somatostatin Sales Share by Application (2021-2026)
Table 36. Global Somatostatin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Somatostatin Revenue Share by Application (2021-2026)
Table 38. Global Somatostatin Price (K Pcs) by Application (2021-2026)
Table 39. United States Somatostatin Sales (K Pcs) by Company (2015-2020)
Table 40. United States Somatostatin Sales Market Share by Company (2015-2020)
Table 41. United States Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 42. United States Somatostatin Sales Market Share by Type (2015-2020)
Table 43. United States Somatostatin Sales (K Pcs) by Application (2015-2020)
Table 44. United States Somatostatin Sales Market Share by Application (2015-2020)
Table 45. Europe Somatostatin Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Somatostatin Sales Market Share by Company (2015-2020)
Table 47. Europe Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Somatostatin Sales Market Share by Type (2015-2020)
Table 49. Europe Somatostatin Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Somatostatin Sales Market Share by Type (2015-2020)
Table 51. China Somatostatin Sales (K Pcs) by Company (2015-2020)
Table 52. China Somatostatin Sales Market Share by Company (2015-2020)
Table 53. China Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 54. China Somatostatin Sales Market Share by Type (2015-2020)
Table 55. China Somatostatin Sales (K Pcs) by Application (2015-2020)
Table 56. China Somatostatin Sales Market Share by Application (2015-2020)
Table 57. Japan Somatostatin Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Somatostatin Sales Market Share by Company (2015-2020)
Table 59. Japan Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Somatostatin Sales Market Share by Type (2015-2020)
Table 61. Japan Somatostatin Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Somatostatin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Somatostatin Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Somatostatin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Somatostatin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Somatostatin Sales Market Share by Application (2015-2020)
Table 69. India Somatostatin Sales (K Pcs) by Company (2015-2020)
Table 70. India Somatostatin Sales Market Share by Company (2015-2020)
Table 71. India Somatostatin Sales (K Pcs) by Type (2015-2020)
Table 72. India Somatostatin Sales Market Share by Type (2015-2020)
Table 73. India Somatostatin Sales (K Pcs) by Application (2015-2020)
Table 74. India Somatostatin Sales Market Share by Application (2015-2020)
Table 75. Merck (Schweiz) AG Corporation Information
Table 76. Merck (Schweiz) AG Description and Business Overview
Table 77. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Merck (Schweiz) AG Somatostatin Product
Table 79. Merck (Schweiz) AG Recent Development
Table 80. SANOFI-AVENTIS FRANCE Corporation Information
Table 81. SANOFI-AVENTIS FRANCE Description and Business Overview
Table 82. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. SANOFI-AVENTIS FRANCE Somatostatin Product
Table 84. SANOFI-AVENTIS FRANCE Recent Development
Table 85. Lyomark Pharma GmbH Corporation Information
Table 86. Lyomark Pharma GmbH Description and Business Overview
Table 87. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Lyomark Pharma GmbH Somatostatin Product
Table 89. Lyomark Pharma GmbH Recent Development
Table 90. ALFA WASSERMANN S.p.A. Corporation Information
Table 91. ALFA WASSERMANN S.p.A. Description and Business Overview
Table 92. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. ALFA WASSERMANN S.p.A. Somatostatin Product
Table 94. ALFA WASSERMANN S.p.A. Recent Development
Table 95. Polypeptide Laboratories, Inc Corporation Information
Table 96. Polypeptide Laboratories, Inc Description and Business Overview
Table 97. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Polypeptide Laboratories, Inc Somatostatin Product
Table 99. Polypeptide Laboratories, Inc Recent Development
Table 100. SAMARTH Corporation Information
Table 101. SAMARTH Description and Business Overview
Table 102. SAMARTH Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. SAMARTH Somatostatin Product
Table 104. SAMARTH Recent Development
Table 105. UBPL Corporation Information
Table 106. UBPL Description and Business Overview
Table 107. UBPL Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. UBPL Somatostatin Product
Table 109. UBPL Recent Development
Table 110. HYBIO Corporation Information
Table 111. HYBIO Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. HYBIO Description and Business Overview
Table 113. HYBIO Somatostatin Product
Table 114. HYBIO Recent Development
Table 115. TianTaiShan Corporation Information
Table 116. TianTaiShan Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. TianTaiShan Description and Business Overview
Table 118. TianTaiShan Somatostatin Product
Table 119. TianTaiShan Recent Development
Table 120. Yangtze River Corporation Information
Table 121. Yangtze River Description and Business Overview
Table 122. Yangtze River Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Yangtze River Somatostatin Product
Table 124. Yangtze River Recent Development
Table 125. Siyao Corporation Information
Table 126. Siyao Description and Business Overview
Table 127. Siyao Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Siyao Somatostatin Product
Table 129. Siyao Recent Development
Table 130. Shuangcheng Corporation Information
Table 131. Shuangcheng Description and Business Overview
Table 132. Shuangcheng Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Shuangcheng Somatostatin Product
Table 134. Shuangcheng Recent Development
Table 135. Hainan Zhonghe Corporation Information
Table 136. Hainan Zhonghe Description and Business Overview
Table 137. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Hainan Zhonghe Somatostatin Product
Table 139. Hainan Zhonghe Recent Development
Table 140. SL PHARM Corporation Information
Table 141. SL PHARM Description and Business Overview
Table 142. SL PHARM Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. SL PHARM Somatostatin Product
Table 144. SL PHARM Recent Development
Table 145. Wuhan Hualong Corporation Information
Table 146. Wuhan Hualong Description and Business Overview
Table 147. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Wuhan Hualong Somatostatin Product
Table 149. Wuhan Hualong Recent Development
Table 150. Qingdao Guoda Corporation Information
Table 151. Qingdao Guoda Description and Business Overview
Table 152. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Qingdao Guoda Somatostatin Product
Table 154. Qingdao Guoda Recent Development
Table 155. Chengdu Shengnuo Corporation Information
Table 156. Chengdu Shengnuo Description and Business Overview
Table 157. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Chengdu Shengnuo Somatostatin Product
Table 159. Chengdu Shengnuo Recent Development
Table 160. Longjin Corporation Information
Table 161. Longjin Description and Business Overview
Table 162. Longjin Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Longjin Somatostatin Product
Table 164. Longjin Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Somatostatin Distributors List
Table 168. Somatostatin Customers List
Table 169. Somatostatin Market Key Trends
Table 170. Somatostatin Key Opportunities and Drivers
Table 171. Somatostatin Market Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Somatostatin Product Picture
Figure 2. Global Somatostatin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Somatostatin Market Share by Application in 2020 & 2026
Figure 6. Hormonal Disorder Examples
Figure 7. Oncology Examples
Figure 8. Metabolic Disorder Examples
Figure 9. Others Examples
Figure 10. Global Somatostatin Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Somatostatin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Somatostatin Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Somatostatin Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Somatostatin Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Somatostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Somatostatin Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Somatostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Somatostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Somatostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Somatostatin Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Somatostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Somatostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Somatostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Somatostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Somatostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Somatostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Somatostatin Players Market Share by Revenue in Somatostatin 2015 & 2019
Figure 28. Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Somatostatin Revenue Share by Type (2015-2020)
Figure 30. Global Somatostatin Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Somatostatin Revenue Share by Application (2015-2020)
Figure 32. Global Somatostatin Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Somatostatin Sales Market Share by Type in 2019
Figure 34. United States Somatostatin Sales Market Share by Type in 2019
Figure 35. Europe Somatostatin Sales Market Share by Company in 2019
Figure 36. Europe Somatostatin Sales Market Share by Type in 2019
Figure 37. Europe Somatostatin Sales Market Share by Application in 2019
Figure 38. China Somatostatin Sales Market Share by Company in 2019
Figure 39. China Somatostatin Sales Market Share by Type in 2019
Figure 40. China Somatostatin Sales Market Share by Application in 2019
Figure 41. Japan Somatostatin Sales Market Share by Company in 2019
Figure 42. Japan Somatostatin Sales Market Share by Type in 2019
Figure 43. Japan Somatostatin Sales Market Share by Application in 2019
Figure 44. Southeast Asia Somatostatin Sales Market Share by Company in 2019
Figure 45. Southeast Asia Somatostatin Sales Market Share by Type in 2019
Figure 46. Southeast Asia Somatostatin Sales Market Share by Application in 2019
Figure 47. India Somatostatin Sales Market Share by Company in 2019
Figure 48. India Somatostatin Sales Market Share by Type in 2019
Figure 49. India Somatostatin Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Somatostatin
Figure 52. Manufacturing Process Analysis of Somatostatin
Figure 53. Somatostatin Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


【掲載企業】

Merck (Schweiz) AG、SANOFI-AVENTIS FRANCE、Lyomark Pharma GmbH、ALFA WASSERMANN S.p.A.、Polypeptide Laboratories, Inc、SAMARTH、UBPL、HYBIO、TianTaiShan、Yangtze River、Siyao、Shuangcheng、Hainan Zhonghe、SL PHARM、Wuhan Hualong、Qingdao Guoda、Chengdu Shengnuo、Longjin

★調査レポート[世界のソマトスタチン市場レポート2020年] (コード:QYR21FB13828)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のソマトスタチン市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆